Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 02/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 28/02/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.54% | +0.36% | +26.77% | +50.10% | 395.27B | |
| Weighted average by Cap. | +1.73% | +1.17% | +35.87% | +75.23% |
